Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting approximately 10 million people world- wide (Planetta et al., 2014; Zigmond and Smeyne, 2014). The principal clinical features of PD ...Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting approximately 10 million people world- wide (Planetta et al., 2014; Zigmond and Smeyne, 2014). The principal clinical features of PD are bradykinesia, rigidity, tremor at rest and postural instability (Planetta et al., 2014). It is known that both PD itself and the use of anti-parkinson drugs are associated with several non-motor symptoms such as cognitive impairment, neuropsychiatric disturbances and sleep, autonomic, and sensory disorders (Park and Stacy, 2009; Foster et al., 2014). The histopathological hallmark of PD is the reduction of dopaminergic cells in the substantia nigra pars compacta, causing dopamine deficiency in spe- cific nuclei of the basal ganglia such as the dorsal striatum (Fearnley and Lees, 1991; Planetta et al., 2014). The disrup- tion of the dopaminergic system has long been regarded as the major cause of PD; however, it has been shown that a widespread involvement of several non-dopaminergic path- ways also contribute to the clinical manifestations of PD (Park et al., 2014).展开更多
BACKGROUND Sarcopenia is the loss of skeletal muscle mass(SMM)and is a sign of cancer cachexia.Patients with advanced renal cell carcinoma(RCC)may show cachexia.AIM To evaluate the amount of SMM in male clear cell RCC...BACKGROUND Sarcopenia is the loss of skeletal muscle mass(SMM)and is a sign of cancer cachexia.Patients with advanced renal cell carcinoma(RCC)may show cachexia.AIM To evaluate the amount of SMM in male clear cell RCC(ccRCC)patients with and without collateral vessels.METHODS In this study,we included a total of 124 male Caucasian patients divided into two groups:ccRCCa group without collateral vessels(n=54)and ccRCCp group with collateral vessels(n=70).Total abdominal muscle area(TAMA)was measured in both groups using a computed tomography imaging-based approach.TAMA measures were also corrected for age in order to rule out age-related effects.RESULTS There was a statistically significant difference between the two groups in terms of TAMA(P<0.05)driven by a reduction in patients with peritumoral collateral vessels.The result was confirmed by repeating the analysis with values corrected for age(P<0.05),indicating no age effect on our findings.CONCLUSION This study showed a decreased TAMA in ccRCC patients with peritumoral collateral vessels.The presence of peritumoral collateral vessels adjacent to ccRCC might be a fine diagnostic clue to sarcopenia.展开更多
文摘Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting approximately 10 million people world- wide (Planetta et al., 2014; Zigmond and Smeyne, 2014). The principal clinical features of PD are bradykinesia, rigidity, tremor at rest and postural instability (Planetta et al., 2014). It is known that both PD itself and the use of anti-parkinson drugs are associated with several non-motor symptoms such as cognitive impairment, neuropsychiatric disturbances and sleep, autonomic, and sensory disorders (Park and Stacy, 2009; Foster et al., 2014). The histopathological hallmark of PD is the reduction of dopaminergic cells in the substantia nigra pars compacta, causing dopamine deficiency in spe- cific nuclei of the basal ganglia such as the dorsal striatum (Fearnley and Lees, 1991; Planetta et al., 2014). The disrup- tion of the dopaminergic system has long been regarded as the major cause of PD; however, it has been shown that a widespread involvement of several non-dopaminergic path- ways also contribute to the clinical manifestations of PD (Park et al., 2014).
文摘BACKGROUND Sarcopenia is the loss of skeletal muscle mass(SMM)and is a sign of cancer cachexia.Patients with advanced renal cell carcinoma(RCC)may show cachexia.AIM To evaluate the amount of SMM in male clear cell RCC(ccRCC)patients with and without collateral vessels.METHODS In this study,we included a total of 124 male Caucasian patients divided into two groups:ccRCCa group without collateral vessels(n=54)and ccRCCp group with collateral vessels(n=70).Total abdominal muscle area(TAMA)was measured in both groups using a computed tomography imaging-based approach.TAMA measures were also corrected for age in order to rule out age-related effects.RESULTS There was a statistically significant difference between the two groups in terms of TAMA(P<0.05)driven by a reduction in patients with peritumoral collateral vessels.The result was confirmed by repeating the analysis with values corrected for age(P<0.05),indicating no age effect on our findings.CONCLUSION This study showed a decreased TAMA in ccRCC patients with peritumoral collateral vessels.The presence of peritumoral collateral vessels adjacent to ccRCC might be a fine diagnostic clue to sarcopenia.